Earnings: Page 9
-
Courtesy of Quest Diagnostics
Quest cuts 2023 COVID tests forecast amid continued slump in demand; Q4 profit plunges
The company performed 1.2 million molecular tests in the fourth quarter, down from 1.9 million in the third quarter and 5.4 million one year ago.
By Nick Paul Taylor • Feb. 3, 2023 -
Permission granted by Becton Dickinson
BD raises full-year forecast, sees Q1 strength in pharmacy automation, pre-fillables
The company’s base businesses helped cushion the impact of declining COVID-19 testing demand.
By Susan Kelly • Feb. 2, 2023 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers forecasts revenue growth to accelerate despite supply chain woes
Lower diagnostics revenue hurt sales in the three months ended Dec. 31.
By Nick Paul Taylor • Feb. 2, 2023 -
Boston Scientific gets Q4 boost from heart, urology sales
Following a series of significant acquisitions, the company said it expects net sales growth of about 5% to 7% in full-year 2023.
By Susan Kelly • Feb. 1, 2023 -
Edwards posts Q4 profit, reaffirms 2023 outlook as patients return
The heart valve specialist said it is optimistic that the healthcare environment will gradually improve this year.
By Susan Kelly • Feb. 1, 2023 -
ChooChin via Getty Images
Stryker expects 2023 growth despite 15% dip in Q4 net income
CEO Kevin Lobo said he expects new product launches and device orders will offset continued “macroeconomic volatility.”
By Elise Reuter • Feb. 1, 2023 -
Peter S Green/MedTech Dive
GE HealthCare posts revenue growth in last quarter before spinoff on imaging, ultrasound units
The company benefitted from “robust end-market demand, improved pricing, and easing supply chain pressures” in the period.
By Peter Green • Jan. 30, 2023 -
Permission granted by ResMed
ResMed quarterly revenue beats estimates as supply chain woes ease
Demand for CPAP devices and respirators remains strong as the company expects to pick up additional market share from rival Philips, and demand grows for its medical SaaS products.
By Susan Kelly • Jan. 27, 2023 -
VCG / Stringer via Getty Images
Intuitive Q4 profit slips on costs to boost share of robotic surgery market
The investment in innovation comes as Intuitive tries to maintain its dominant position in the face of rivals including Johnson & Johnson and Medtronic.
By Nick Paul Taylor • Jan. 25, 2023 -
Courtesy of 3M.
3M’s healthcare unit Q4 earnings drop on nurse shortages, falling hospital budgets
Elective healthcare procedure volumes were about 90% of pre-COVID levels.
By Nick Paul Taylor • Jan. 25, 2023 -
Courtesy of Johnson&Johnson
J&J sees Abiomed adding to revenue in 2024; Q4 sales drop
Foreign-exchange fluctuations helped curb revenue in the period.
By Peter Green • Jan. 24, 2023 -
Jacob Bell/MedTech Dive
Medtech companies start 2023 on ‘optimistic’ note amid earnings forecasts, staffing: J.P. Morgan
Executive comments at the healthcare conference in San Francisco suggest companies expect staffing pressures and supply constraints to improve in 2023, analysts say.
By Elise Reuter • Jan. 17, 2023 -
Courtesy of Intuitive Surgical
Intuitive forecasts 12%-16% growth in procedures in 2023 even as da Vinci robot sales slowed in Q4
For hospitals that have been reporting growth in robotic procedures, “da Vinci is a relative priority in their capital budgets,” the company said.
By Elise Reuter • Jan. 11, 2023 -
Courtesy of GuardantHealth
Guardant Health posts revenue growth in Q4 on higher clinical testing volumes
The oncology diagnostics company’s preliminary results beat analyst estimates.
By Nick Paul Taylor • Jan. 10, 2023 -
Courtesy of Dexcom
Dexcom forecasts 2023 revenue to rise as much as 20% on G7 launch
Sales are expected to reach $3.35 billion to $3.49 billion for the full year.
By Elise Reuter • Jan. 9, 2023 -
Johnny Greig via Getty Images
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
atiatiati via Getty Images
Teleflex launches another round of restructuring
Rising costs are pushing the device maker to incur restructuring liabilities of $31 million to $40 million.
By Elise Reuter • Nov. 23, 2022 -
Permission granted by Medtronic
Medtronic lowers full-year forecast, citing drop in procedure growth
A slower-than-expected recovery in certain procedures, including TAVR and spinal cord stimulation, curbed quarterly profit and revenue.
By Elise Reuter • Nov. 22, 2022 -
Adeline Kon/Healthcare Dive/MedTech Dive
Q3 Earnings Wrap: Bumpy time for medtech with inflation, FX, supply woes
Macroeconomic pressures were a persistent theme for the industry, with workforce reductions a part of the fallout for some companies.
By Susan Kelly • Nov. 21, 2022 -
Permission granted by Becton Dickinson
BD says inflationary pressures persist; COVID-19 test sales plunge
Revenue at the company’s medical segment grew in the fourth quarter, helped by the acquisition of pharmacy automation company Parata.
By Elise Reuter • Nov. 10, 2022 -
Retrieved from Siemsens Website on July 01, 2022
Siemens Healthineers beats sales forecasts on imaging demand as diagnostic pressures prompt restructuring
Siemens Healthineers is revamping its diagnostics unit after concluding that “external headwinds [are] outweighing operational improvements.”
By Nick Paul Taylor • Nov. 9, 2022
Previous
To find more content, use the "Topics" in the menu above.
